aklief
(trifarotene)Galderma Laboratories, L.P.
Usage: AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.
12 results
altreno
(tretinoin)Bausch Health US, LLCUsage: ALTRENO® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.arazlo
(tazarotene)Bausch Health US, LLCUsage: ARAZLO® (tazarotene) lotion, 0.045% is indicated for the topical treatment of acne vulgaris in patients aged 9 and older.duobrii
(halobetasol propionate and tazarotene)Bausch Health US, LLCUsage: DUOBRII® (halobetasol propionate and tazarotene) Lotion is indicated for the topical treatment of plaque psoriasis in adults.epiduo
(adapalene and benzoyl peroxide)Galderma Laboratories, L.P.Usage: EPIDUO gel is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.panretin
(alitretinoin)Concordia Pharmaceuticals Inc.Usage: Panretin® gel is indicated for the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. It is not suitable for cases requiring systemic anti-KS therapy or where significant symptoms are present.sohonos
(palovarotene)Ipsen Biopharmaceuticals, Inc.Usage: SOHONOS is indicated for reducing the volume of new heterotopic ossification in adults and pediatric patients with fibrodysplasia ossificans progressiva (FOP), specifically in females aged 8 years and older and males aged 10 years and older.targretin
(bexarotene)Bausch Health US, LLCUsage: Targretin (bexarotene) gel 1% is indicated for the topical treatment of cutaneous lesions in patients with Stage IA and IB CTCL, specifically for those with refractory or persistent disease or who have not tolerated other therapies.targretin
(bexarotene)Bausch Health US, LLCUsage: TARGRETIN® (bexarotene) Capsules are indicated for treating cutaneous manifestations of cutaneous T-cell lymphoma in patients who have not responded to at least one prior systemic therapy.tazarotene
(Tazarotene)Taro Pharmaceuticals U.S.A., Inc.Usage: Tazarotene cream, 0.1%, is indicated for the topical treatment of plaque psoriasis and acne vulgaris in patients.